Aurora Cannabis Inc. · TSX:ACB
Aurora Cannabis — Q4 2024 Earnings Presentation
17 slides from Aurora Cannabis's earnings presentation, Jun 20, 2024
Slide 1: Investor Presentation June 2024
INVESTOR PRESENTATION JUNE 2024
Slide 2: Disclaimer
Disclaimer CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS: Certain information contained in this presentation constitutes forward-looking statements under applicable securities laws. Any statements that are contained in this presentation that are not statements of historical fact may be deemed
Slide 3: Diversified Global Business Model
Diversified Global Business Model Focus on Defensive, Stable, High Margin Segments International Canadian Medical Plant Propagation Adult Recreational Science & Medical #1 Canadian Medical Innovation Controlling interest in Bevo, one of Ability to deliver products share by revenue. the largest suppl
Slide 4: Leading Global Cannabis Platform
Leading Global Cannabis Platform • Global medical cannabis net revenue(1) up 20% in FY24 compared to the prior year period. • Increased revenue primarily attributable to higher sales in Europe and Australia following the success of newly launched innovative cultivars. • Following the acquisition of
Slide 5: Leadership in Key Global Cannabis Markets
Leadership in Key Global Cannabis Markets UNITED KINGDOM: 68m population • Solid market position through relationships with POLAND: 40m population key distributors and supply of Channel Islands; a • #2 market share in rapidly growing medical market high-growth market due to less rigid prescriber reg
Slide 6: Canadian Medical Leadership
Canadian Medical Leadership Aurora is leading the market with 4 owned brands and a wide variety of marketplace offerings Consistent Revenue Stream and Margin Leader • #1 Canadian Medical Share by revenue; ~10% revenue(1) growth year over year Value Core • Direct-to-patient controlled distribution mo
Slide 7: Latest Medical Innovations
Latest Medical Innovations Dried Flower Lotions & Topicals Oils & Capsules Edibles & Beverages Vapes & Concentrates Veteran focused Strains for CBD Dominant, THC Free CBD Oral sprays Minor Cannabinoid gummies • Live and cured Resin Hero’s innovation Creams and Bath bombs Beverages 1 gram vapes • 100
Slide 8: A Compelling Portfolio of Adult Recreational Brands
A Compelling Portfolio of Adult Recreational Brands Value Core Premium Super Premium Biggest flavour, biggest clouds. Mid-to-high THC offerings with proprietary House-bred strains. Innovative products Ultra-premium, high-terpene, high-potency The best value; Always. offerings that offer exciting and
Slide 9: Upcoming Innovation
Upcoming Innovation New SKUs designed to continuously delight consumers • Introduction of our latest high THC, high terpene cultivars under the San Rafael ‘71 brand, developed through our proprietary genetic breeding program. • Announcing the first launch of Dried Flower under the Greybeard brand si
Slide 10: Sales and Marketing Support
Sales and Marketing Support • Activating national campaign to maximize the awareness and purchase consideration for Tasty's Vapes. o Campaign elements include in-store visits to retailers for education sessions with sampling, in-store display activations, digital cannabis media investment • Activati
Slide 11: MedReleaf Australia Acquisition
MedReleaf Australia Acquisition Aurora has been partnered with MedReleaf Australia, the #2 distributor of medical cannabis products in Australia, since 2017. In February 2024, Aurora acquired the remaining approximately 90% equity interest of MedReleaf Australia. The acquisition makes Aurora the lar
Slide 12: Plant Propagation Overview
Plant Propagation Overview • Aurora holds a controlling interest in Bevo Farms, an industry leader in plant propagation and one of the largest suppliers of propagated vegetables and ornamental plants in North America. • Bevo is cash flow positive on an annualized basis and contributed revenues of ~$
Slide 13: Science & Innovation Program
Science & Innovation Program A state-of-the-art breeding facility in Vancouver Island’s Comox Valley: • Built specifically to find the next big genetics: high yielding, high cannabinoid strains with unique terpene flavours and distinctive experiences • Delivered 19 new proprietary cultivars, grown a
Slide 14: Key Takeaways
Key Takeaways Opening the Largest global medical cannabis company in nationally legal markets World to Diversified and growing footprint in high-margin medical cannabis markets across the globe Cannabis Consistent sequential and year-over-year revenue growth, including 20% YoY growth in our gl
Slide 15: Senior Management Team
Senior Management Team Miguel Martin Director & CEO Miguel’s career spans nearly 30 years in consumer- packaged goods, covering various regulated categories and fast-moving markets. Miguel is the former CEO & President of Reliva. Simona King Nathalie Clark Alex Miller Chief Financial Officer EVP, Ge
Slide 16: Board of Directors
Board of Directors Ronald Funk Miguel Martin Chairman Director & CEO Ron brings over 30 years of Miguel’s career spans nearly experience in business and 30 years in consumer- consulting and has worked with packaged goods, covering clients in a range of industries, various regulated categories includ
Slide 17: Investor Presentation
INVESTOR PRESENTATION Email: aurora@icrinc.com Website: auroramj.com/investors